Symbol="ABVC"
AssetType="Common Stock"
Name="ABVC Biopharma Inc"
Description="American BriVision (Holding) Corporation, a clinical-stage biopharmaceutical company, develops drugs and medical devices to meet unmet medical needs in the United States. "
CIK="1173313"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11 SAWYERS PEAK DRIVE, GOSHEN, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="10255000"
EBITDA="-10776994"
PERatio="None"
PEGRatio="None"
BookValue="0.051"
DividendPerShare="0"
DividendYield="0"
EPS="-3.7"
RevenuePerShareTTM="0.033"
ProfitMargin="0"
OperatingMarginTTM="-10.07"
ReturnOnAssetsTTM="-0.592"
ReturnOnEquityTTM="-2.665"
RevenueTTM="1072400"
GrossProfitTTM="350710"
DilutedEPSTTM="-3.7"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="3.999"
AnalystTargetPrice="2.02"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="66.6"
PriceToBookRatio="4.08"
EVToRevenue="75.39"
EVToEBITDA="-1.46"
Beta="0.324"
num_52WeekHigh="11.9"
num_52WeekLow="2.89"
num_50DayMovingAverage="5.57"
num_200DayMovingAverage="6.77"
SharesOutstanding="3308100"
DividendDate="2019-05-08"
ExDividendDate="None"
symbol="ABVC"
open="4.08"
high="4.40"
low="2.89"
price="3.10"
volume="1045490.00"
latest_trading_day="2023-07-27"
previous_close="5.32"
change="-2.22"
change_percent="-41.7293%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="70"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="393155"
Change_recent_avg="-0.02"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-1.58"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_30"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="1126"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0159.jpeg"
image_negative_thumbnail_id_2="97"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_neutral_thumbnail_id_1="580"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="682"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0026.jpeg"
image_positive_thumbnail_id_2="645"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0063.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
